These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 15711040)

  • 1. Biocompatibility parameters of different dialysis membranes assessed during systemic inflammation.
    Gueler F; Gwinner W; Schiborr C; Martin M; Klos A; Kirsch T; Fiebeler A; Haller H; Fliser D
    Blood Purif; 2005; 23(3):196-202. PubMed ID: 15711040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in bio-incompatibility among four biocompatible dialyzer membranes using in maintenance hemodialysis patients.
    Zhang DL; Liu J; Cui WY; Ji DY; Zhang Y; Liu WH
    Ren Fail; 2011; 33(7):682-91. PubMed ID: 21787159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.
    Girndt M; Lengler S; Kaul H; Sester U; Sester M; Köhler H
    Am J Kidney Dis; 2000 Jan; 35(1):95-104. PubMed ID: 10620550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the hemodialysis membrane on the inflammatory reaction in vivo.
    Schindler R; Boenisch O; Fischer C; Frei U
    Clin Nephrol; 2000 Jun; 53(6):452-9. PubMed ID: 10879665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
    Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
    J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of dialyzer geometry on blood coagulation and biocompatibility.
    Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
    Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis?
    Mrowka C; Heintz B; Sieberth HG
    Clin Nephrol; 1999 Nov; 52(5):312-21. PubMed ID: 10584995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
    Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
    Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal.
    Krieter DH; Lemke HD; Wanner C
    Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status.
    Morena M; Jaussent I; Chalabi L; Bargnoux AS; Dupuy AM; Badiou S; Rakic C; Thomas M; Canaud B; Cristol JP; Michel F
    Hemodial Int; 2010 Oct; 14(4):403-10. PubMed ID: 20955273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study.
    Vaslaki LR; Berta K; Major L; Weber V; Weber C; Wojke R; Passlick-Deetjen J; Falkenhagen D
    Artif Organs; 2005 May; 29(5):406-12. PubMed ID: 15854217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory response of a new synthetic dialyzer membrane. A randomised cross-over comparison between polysulfone and helixone.
    Stefoni S; Colì L; Cianciolo G; Donati G; Ruggeri G; Ramazzotti E; Pohlmeier R; Lang D
    Int J Artif Organs; 2003 Jan; 26(1):26-32. PubMed ID: 12602466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
    Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low- and high-flux dialyzers on oxidative stress and insulin resistance.
    Chu PL; Chiu YL; Lin JW; Chen SI; Wu KD
    Blood Purif; 2008; 26(2):213-20. PubMed ID: 18285698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
    Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
    Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.